| Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis G Disanto, C Barro, P Benkert, Y Naegelin, S Schädelin, A Giardiello, ... Annals of neurology 81 (6), 857-870, 2017 | 959 | 2017 |
| Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis SE Baranzini, J Wang, RA Gibson, N Galwey, Y Naegelin, F Barkhof, ... Human molecular genetics 18 (4), 767-778, 2009 | 569 | 2009 |
| Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis C Barro, P Benkert, G Disanto, C Tsagkas, M Amann, Y Naegelin, ... Brain 141 (8), 2382-2391, 2018 | 441 | 2018 |
| Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257, 2022 | 249 | 2022 |
| Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients C Lukas, MH Sombekke, B Bellenberg, HK Hahn, V Popescu, K Bendfeldt, ... Radiology 269 (2), 542-552, 2013 | 166 | 2013 |
| Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis A Papadopoulou, N Müller-Lenke, Y Naegelin, G Kalt, K Bendfeldt, ... Multiple Sclerosis Journal 19 (10), 1290-1296, 2013 | 150 | 2013 |
| Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis C Lukas, DL Knol, MH Sombekke, B Bellenberg, HK Hahn, V Popescu, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (4), 410-418, 2015 | 148 | 2015 |
| Switching from natalizumab to fingolimod: a randomized, placebo-controlled study in RRMS L Kappos, EW Radue, G Comi, X Montalban, H Butzkueven, H Wiendl, ... Neurology 85 (1), 29-39, 2015 | 135 | 2015 |
| The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients Ö Yaldizli, IK Penner, K Frontzek, Y Naegelin, M Amann, A Papadopoulou, ... Multiple Sclerosis Journal 20 (3), 356-364, 2014 | 121 | 2014 |
| Intravenous levetiracetam: treatment experience with the first 50 critically ill patients S Rüegg, Y Naegelin, M Hardmeier, DT Winkler, S Marsch, P Fuhr Epilepsy & Behavior 12 (3), 477-480, 2008 | 121 | 2008 |
| Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis—a longitudinal voxel-based morphometry study K Bendfeldt, P Kuster, S Traud, H Egger, S Winklhofer, N Mueller-Lenke, ... Neuroimage 45 (1), 60-67, 2009 | 114 | 2009 |
| Biplanar MRI for the assessment of the spinal cord in multiple sclerosis K Weier, J Mazraeh, Y Naegelin, A Thoeni, JG Hirsch, T Fabbro, N Bruni, ... Multiple Sclerosis Journal 18 (11), 1560-1569, 2012 | 101 | 2012 |
| Measuring and validating the levels of brain-derived neurotrophic factor in human serum Y Naegelin, H Dingsdale, K Säuberli, S Schädelin, L Kappos, YA Barde Eneuro 5 (2), 2018 | 99 | 2018 |
| Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis K Weier, IK Penner, S Magon, M Amann, Y Naegelin, M Andelova, ... PloS one 9 (1), e86916, 2014 | 99 | 2014 |
| Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis M Gschwind, M Hardmeier, D Van De Ville, MI Tomescu, IK Penner, ... NeuroImage: Clinical 12, 466-477, 2016 | 95 | 2016 |
| Spinal cord volume loss: a marker of disease progression in multiple sclerosis C Tsagkas, S Magon, L Gaetano, S Pezold, Y Naegelin, M Amann, ... Neurology 91 (4), e349-e358, 2018 | 86 | 2018 |
| Serum neurofilament light chain levels in the intensive care unit: comparison between severely ill patients with and without coronavirus disease 2019 R Sutter, L Hert, GM De Marchis, R Twerenbold, L Kappos, Y Naegelin, ... Annals of Neurology 89 (3), 610-616, 2021 | 79 | 2021 |
| Association of rituximab treatment with disability progression among patients with secondary progressive multiple sclerosis Y Naegelin, P Naegelin, S von Felten, J Lorscheider, J Sonder, ... JAMA neurology 76 (3), 274-281, 2019 | 75 | 2019 |
| Multivariate pattern classification of gray matter pathology in multiple sclerosis K Bendfeldt, S Klöppel, TE Nichols, R Smieskova, P Kuster, S Traud, ... Neuroimage 60 (1), 400-408, 2012 | 65 | 2012 |
| Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing‐remitting multiple sclerosis K Bendfeldt, JO Blumhagen, H Egger, P Loetscher, N Denier, P Kuster, ... Human brain mapping 31 (10), 1542-1555, 2010 | 59 | 2010 |
